These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3608251)

  • 1. No evidence for endotoxin transfer across high flux polysulfone membranes.
    Bommer J; Becker KP; Urbaschek R; Ritz E; Urbaschek B
    Clin Nephrol; 1987 Jun; 27(6):278-82. PubMed ID: 3608251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of endotoxins in high-flux dialysis.
    Smollich BP; Falkenhagen D; Schneidewind J; Mitzner S; Klinkmann H
    Nephrol Dial Transplant; 1991; 6 Suppl 3():83-5. PubMed ID: 1775273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro assessment of dialysis membrane as an endotoxin transfer barrier: geometry, morphology, and permeability.
    Henrie M; Ford C; Andersen M; Stroup E; Diaz-Buxo J; Madsen B; Britt D; Ho CH
    Artif Organs; 2008 Sep; 32(9):701-10. PubMed ID: 18684209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of lipid A and Pseudomonas aeruginosa endotoxin from dialysis fluids by high-flux polysulfone ultrafilter (dialyzer).
    Rafiee-Tehrani M; Farrokhnia R; Falkenhagen D; Weber C
    PDA J Pharm Sci Technol; 1996; 50(5):306-10. PubMed ID: 8973116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential transfer of endotoxin across high-flux polysulfone membranes.
    Bommer J; Becker KP; Urbaschek R
    J Am Soc Nephrol; 1996 Jun; 7(6):883-8. PubMed ID: 8793797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of endotoxin-contaminated dialysate and polysulfone or cellulosic membranes on the release of TNF alpha during simulated dialysis.
    Arduino MJ; Bland LA; McAllister SK; Favero MS
    Artif Organs; 1995 Sep; 19(9):880-6. PubMed ID: 8687293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the permeability of high-flux dialyzer membranes for bacterial pyrogens.
    Schindler R; Christ-Kohlrausch F; Frei U; Shaldon S
    Clin Nephrol; 2003 Jun; 59(6):447-54. PubMed ID: 12834177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in-vitro haemodialysis.
    Ureña P; Herbelin A; Zingraff J; Lair M; Man NK; Descamps-Latscha B; Drüeke T
    Nephrol Dial Transplant; 1992; 7(1):16-28. PubMed ID: 1316577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dialysate and biocompatibility in hemodialysis].
    Berland Y
    Nephrologie; 1998; 19(6):329-34. PubMed ID: 9836194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dialyzer clearances and mass transfer-area coefficients for small solutes at low dialysate flow rates.
    Leypoldt JK; Kamerath CD; Gilson JF; Friederichs G
    ASAIO J; 2006; 52(4):404-9. PubMed ID: 16883120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiological effects of a limulus amoebocyte-lysate-positive substance during haemodialysis.
    Darenkov AF; Yermolenko VM; Sinyukhin VN; Stetsyuk EA; Kochlov AP; Yarmolinski JS
    Nephrol Dial Transplant; 1991; 6 Suppl 3():62-5. PubMed ID: 1775271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Middle molecule removal in low-flux polysulfone dialyzers: impact of flows and surface area on whole-body and dialyzer clearances.
    Eloot S; de Vos JY; de Vos F; Hombrouckx R; Verdonck P
    Hemodial Int; 2005 Oct; 9(4):399-408. PubMed ID: 16219061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis membranes on inflammatory markers: a randomized, single-blinded, controlled clinical trial.
    Kerr PG; Sutherland WH; de Jong S; Vaithalingham I; Williams SM; Walker RJ
    Am J Kidney Dis; 2007 Apr; 49(4):533-9. PubMed ID: 17386321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do cytokine-inducing substances penetrate through dialysis membranes and stimulate monocytes?
    Kumano K; Yokota S; Nanbu M; Sakai T
    Kidney Int Suppl; 1993 Jun; 41():S205-8. PubMed ID: 8320922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrafiltration and endotoxin removal from dialysis fluids.
    Di Felice A; Cappelli G; Facchini F; Tetta C; Cornia F; Aimo G; Lusvarghi E
    Kidney Int Suppl; 1993 Jun; 41():S201-4. PubMed ID: 8320921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the association between increasing membrane pore size and endotoxin permeability using a novel experimental dialysis simulation set-up.
    Schepers E; Glorieux G; Eloot S; Hulko M; Boschetti-de-Fierro A; Beck W; Krause B; Van Biesen W
    BMC Nephrol; 2018 Jan; 19(1):1. PubMed ID: 29304774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On line filtration of dialysate: structural and functional features of an asymmetric polysulfone hollow fiber ultrafilter (Diaclean).
    Ronco C; Cappelli G; Ballestri M; Lusvarghi E; Frisone P; Milan M; Dell'Aquila R; Crepaldi C; Dissegna D; Gastaldon F
    Int J Artif Organs; 1994 Oct; 17(10):515-20. PubMed ID: 7896424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotoxin transfer through dialysis membranes: small- versus large-pore membranes.
    Vanholder R; Van Haecke E; Veys N; Ringoir S
    Nephrol Dial Transplant; 1992; 7(4):333-9. PubMed ID: 1317524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of cytokine-inducing bacterial products across hemodialyzer membranes in the presence of plasma or whole blood.
    Pereira BJ; Sundaram S; Barrett TW; Butt NK; Porat R; King AJ; Dinarello CA
    Clin Nephrol; 1996 Dec; 46(6):394-401. PubMed ID: 8982556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotoxin rejection by ultrafiltration through high-flux, hollow fiber filters.
    Yamamoto C; Kim ST
    J Biomed Mater Res; 1996 Nov; 32(3):467-71. PubMed ID: 8897153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.